-
1
The interplay between gut microbiota and host immunity is crucial for maintaining intestinal and systemic homeostasis.
-
2
Dysbiosis is linked to various conditions, including inflammatory bowel disease, irritable bowel syndrome, type 2 diabetes, and chronic obstructive pulmonary disease.
-
3
Akkermansia muciniphila shows potential as a therapeutic candidate, modulating immune responses and enhancing epithelial barrier integrity.
-
4
Natural polysaccharides can serve as dual-action therapeutics, promoting beneficial bacteria and reinforcing intestinal barrier function.
-
5
The research emphasizes a shift from association to causality in microbiota studies, highlighting the need for advanced methodologies and targeted interventions.
